ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 1,637,125 | $27,684,000 | 5.54% |
| BVF INC/IL | 606,801 | $10,261,000 | 2.54% |
| Sarissa Capital Management LP | 633,000 | $10,704,000 | 2.36% |
| Glacier Peak Capital LLC | 38,048 | $989,000 | 0.85% |
| BB BIOTECH AG | 1,008,542 | $17,054,000 | 0.68% |
| FT Options LLC | 31,296 | $529,000 | 0.55% |
| Rhenman & Partners Asset Management AB | 150,000 | $2,537,000 | 0.50% |
| Virtus ETF Advisers LLC | 11,011 | $186,000 | 0.26% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 806,105 | $13,631,000 | 0.20% |
| WASATCH ADVISORS LP | 759,183 | $12,519,000 | 0.19% |